- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.01. | Gilead and LEO Pharma link on programmes for inflammatory conditions | ||
| 13.01. | JP Morgan 2025: NVIDIA partners with IQVIA, Illumina and Mayo Clinic | ||
| 13.01. | Small matter, big challenges: Nano milling in a sterilised environment | ||
| 13.01. | JP Morgan 2025: GSK acquires IDRx in $1.15bn deal | ||
| 13.01. | The promising future of regenerative medicine | ||
| 13.01. | Mediar Therapeutics signs licensing deal with Eli Lilly for IPF treatment | ||
| 13.01. | Intellia slashes workforce by 27% to focus on late stage CRISPR candidates | ||
| 10.01. | FDA CDER director Patrizia Cavazzoni announces resignation | ||
| 10.01. | Alzheimer's total prevalent cases to reach 22.51 million in 8MM in 2033 | ||
| 10.01. | Climb Bio enters licensing deal with Mabworks for CLYM116 development | ||
| 10.01. | A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours | ||
| 10.01. | Light Horse emerges with $62m and Novartis partnership worth up to $1bn | ||
| 10.01. | Coave Therapeutics raises $33m in funding to advance ALIGATER platform | ||
| 10.01. | Newron and Myung In Pharm sign agreement for evenamide development | ||
| 10.01. | Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe | ||
| 09.01. | Samsung Biologics and LigaChem extend ADC services deal | ||
| 09.01. | UK-based Verdiva launches with $410m and an oral GLP-1RA candidate | ||
| 09.01. | Palforzia's peanut allergy treatment use in Europe expanded to toddlers | ||
| 09.01. | Aspect Biosystems secures $115m to develop tissue therapeutics | ||
| 09.01. | Novo Nordisk and Valo expand cardiometabolic drug partnership | ||
| 08.01. | Sanofi taps Alloy Therapeutics for CNS antisense drug development | ||
| 08.01. | Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses | ||
| 08.01. | MSD's HPV vaccine gains China NMPA's expanded approval for males | ||
| 08.01. | Chugai and Araris enter $780m ADC research collaboration | ||
| 08.01. | Vertex and Orna sign partnership to improve efficiencies of gene therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
